ALS (also known as Lou Gehrig's Disease) is a progressive neuromuscular disease in which nerve cells die and leave voluntary muscles paralyzed.

Every day two or three Canadians die of the disease.

Learn More About ALS

Join the #IceBucketChallengeSupport an ALS EventEvents CalendarHealthcare ProvidersClinical TrialsALS and Youth

 

    

   

 

ALS News

The ALS Canada Board is seeking nominations for Directors to serve on the Board of Directors.

ALS Canada is a registered charity, dedicated to supporting Canadians living with ALS (amyotrophic lateral sclerosis) and investing in research to make ALS a treatable, not terminal disease. 

A large consortium of researchers from six countries have definitively identified a new ALS gene called TANK-binding kinase 1 (TBK1) by performing a rigorous study that involved sequencing of more than 2800 people with ALS compared with more than 6000 control samples. Canadian researcher Dr. Guy Rouleau, Director of the Montreal Neurological Institute and his colleague Dr. Patrick A. Dion, along with current Tim E. Noël (ALS Canada) Postdoctoral Fellowship recipient Dr. Claire Leblond are authors on this landmark manuscript, recently published early online for the top journal Science. 

The Arthur J. Hudson Translational Team Grant was first announced on May 3, 2014 at the ALS Canada Research Forum and the inaugural competition deadline was July 1, 2014. This new grant program is designed to fund teams of Canadian researchers to accelerate the movement of ideas out of the laboratory and into the clinic with the hope of assisting development of new therapeutics for ALS. It is the cornerstone of our ALS Canada Research Program designed to emphasize bench-to-bedside translation.

ALS Society of Canada
Vice President Fund Development 

ALS Canada is looking for an energetic professional to join our team. We want to find a person who understands the critical contribution they will make to our vision to make a difference in the lives of people living with ALS today and to a future, where ALS will be a treatable, not terminal disease. They love a challenge, developing a plan and orchestrating a multi-disciplinary team to achieve outstanding outcomes in fund development and donor relations. Could this be you?

GivingTuesday is a global day of giving. It is a time to celebrate and give back to our fellow neighbours, friends and charitable organizations in need. GivingTuesday is a movement for everyone who wants to give something back.
 
You can do your part by making a donation, volunteering time, and even raising awareness with #givingtuesday. 

There are many different ways you can support the ALS community. Visit here and learn how you can get involved and give back.

The ALS Canada Research program was established to fund the top ALS research in Canada to meet ALS Canada’s strategic vision to find a treatment for ALS. Thanks to your support, we are pleased to announce the recipients of the 2014 ALS Canada-Brain Canada Discovery Grants.

This announcement marks the first grants named in the partnership with Brain Canada. As part of the ALS community, we are tremendously excited about that this partnership is able to fund world class projects that will ultimately move the field of ALS research forward.